Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck

International Journal of Cancer

Volumn 73, Issue 4, 1997, Pages 551-555

  Patel, Vyomesh ^a,d   Jakus, Judit ^a,c   Harris, Candice M ^a   Ensley, John F ^b   Robbins, Keith C ^a   Yeudall, W Andrew ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c CTRL RES INSTITUTE FOR CHEMISTRY   (Hungary)

^d Building 30 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIVISION; CELL LYSATE; CHROMOSOME 9P; DISEASE ASSOCIATION; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; KERATINOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASES; CYCLINS; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR CELLS, CULTURED;

EID: 0031468604     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971114)73:4<551::AID-IJC16>3.0.CO;2-C     Document Type: Article

References (37)

1. AAGAARD, L., LUKAS, J., BARTKOVA, J., KJERULFF, A.A., STRAUSS, M. and BARTEK, J., Aberrations of p16Ink4 and retinoblastoma tumor-suppressor genes occur in distinct subsets of human cancer cell lines. Int. J. Cancer, 61, 115-120 (1995).
2. ADAMS, P.D. and KAELIN, W.G., JR., The cellular effects of E2F overexpression. Curr. Topics Microbiol. Immunol., 208, 79-93 (1996).
3. 1 regulation in human head and neck cancer. Cancer Res., 55, 949-956 (1995).
4. BURNS, J.E., BAIRD, M.C., CLARK, L.J., BURNS, P.A., EDINGTON, K.G., CHAPMAN, C. MITCHELL, R., ROBERTSON, G., SOUTAR, D. and PARKINSON, E.K., Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Brit. J. Cancer, 67, 1274-1284 (1993).
5. CHANG, S.E., FOSTER, S., BETTS, D. and MARNOCK, W.E., DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int. J. Cancer, 52, 896-902 (1992).
6. Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-880 (1996).
7. COLTRERA, M.D., ZARBO, R.J., SAKR, W.A. and GOWN, A.M., Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Amer. J. Pathol., 141, 817-825 (1992).
8. DOBASHI, Y., KUDOH, T., MATSUMINE, A., TOYOSHIMA, K. and AKIYAMA, T., Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J. biol. Chem., 270, 23031-23037 (1995).
9. 1 arrest and apoptosis. Cancer Res., 54, 1169-1174 (1994).
10. GILLETT, C., FANTL, V., SMITH, R., FISHER, C., BARTEK, J., DICKSON, C., BARNES, D. and PETERS, G., Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
11. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Develop., 9, 2939-2952 (1994).
12. HAN, E.K.-H., SGAMBATO, A., JIANG, W., ZHANG, Y.-J., SANTELLA, R.M., DOKI, Y., CACACE, A.M., SCHIEREN, I. and WEINSTEIN, I.B., Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10, 953-961 (1995).
13. HE, J., ALLEN, J.R., COLLINS, V.R. ALLALUNIS-TURNER, M.J., GODBOUT, R., DAY, R.S. and JAMES, C.D., CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res., 54, 5804-5807 (1994).
14. HUNTER, T. and PINES, J., Cyclins and cancer II. Cyclin D and CDK inhibitors come of age. Cell. 79, 573-582 (1994).
15. JAKUS, J. and YEUDALL, W.A., Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Oncogene, 12, 2369-2376 (1996).
16. KATO, J.-Y., MATSUSHIME, H., HIEBERT, S.W., EWEN, M.E. and SHERR, C.J., Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Develop., 7, 331-342 (1993).
17. KEYOMARSI, K. and PARDEE, A.B., Redundant cyclin overexpression and aene amplification in breast cancer cells. Proc. nat. Acad. Sci. (Wash.), 90, 1112-1116 (1993).
18. KOBAYASHI, I., MATSUO, K., OZEKI, S., OHISHI, M., ISHIBASHI, Y. and SAKAI, H., The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining. Hum. Pathol., 26, 907-913 (1995).
19. KRANENBERG, O., VAN DER EB, A.J. and ZANTEMA, A., Cyclin D1 is an essential mediator of apoptotic cell death. EMBO J., 15, 46-54 (1996).
20. LAMMIE, G.A., FANTL, V., SMITH, R., SCHUURING, E., BROOKES, S., MICHALIDES, R., DICKSON, C., ARNOLD, A. and PETERS, G., D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6, 439-444 (1991).
21. LANE, D.P., p53: guardian of the genome. Nature (Lond.), 358, 15-16 (1992).
22. LESACA, E.E., ENSLEY, J.F. and YEUDALL, W.A., Cellular factors may enable squamous carcinoma cells to overcome TGFβ-mediated repression of CDK2 activity. Oral Oncol. Europ. J. Cancer (1991) (In press).
23. LI, R., WAGA, S., HANNON, G.J., BEACH, D. and STILLMAN, B., Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371, 534-537 (1994).
24. LIGGETT, W.H., JR., SEWELL, D.A., ROCCO, J., AHRENDT, S.A., KOCH, W. and SIDRANSKY, D., p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56, 4119-4123 (1996).
25. INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13, 561-568 (1996).
26. WAF1 induction are important early events. Cell Growth Diff., 7, 1291-1304 (1996).
27. MIN, B.-M., BAEK, J.-H., SHIN, K.-H., GUJULUVA, C.N., CHERRICK, H.M. and PARK, N.-H., Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Oral Oncol. Europ. J. Cancer, 30B, 338-345 (1994).
28. NATIONAL CANCER INSTITUTE, Cancer statistics review: 1973-1988, NCI, Division of Cancer Prevention and Control, Surveillance Program, NIH publication 91-2789, Bethesda, MD (1991).
29. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
30. PINES, J., The cell cycle kinases. Semin. Cancer Biol., 5, 305-313 (1994).
31. SAKAI, E., RIKIMARU, K., UEDA, M., MATSUMOTO, Y., ISHII, N., ENOMOTO, S., YAMAMOTO, H. and TSUCHIDA, N., The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int. J. Cancer, 52, 867-872 (1992).
32. 1 cyclin-dependent kinases. Genes Develop., 9, 1149-1163 (1995).
33. WEINBERG, R.A., The retinoblustoma protein and cell cycle control. Cell, 81, 323-330 (1995).
34. INK4A, MTS1) gene and other loci on human chromosome 9. Int. J. Cancer, 65, 840-846 (1996).
35. YEUDALL, W.A., CRAWFORD, R.Y., ENSLEY, J.F. and ROBBINS, K.C., MTS1/ CDK41 is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis, 15, 2683-2686 (1994).
36. YEUDALL, W.A., JAKUS, J., ENSLEY, J.F. and ROBBINS, K.C., Functional characterization of p53 molecules expressed in human squamous cell carcinomas. Mol. Carcinogenesis, 18, 89-96 (1997).
37. YEUDALL, W.A., PATERSON, I.C., PATEL, V. and PRIME, S.S., Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53. Oral Oncol. Europ. J. Cancer, 31B, 136-143 (1995).